{ "items": [ "\n\n
Peto TJ. et al, (2022), The Lancet Infectious Diseases, 22, 867 - 878
\n \n \n \n\n \n
\n \n \nKunasol C. et al, (2022), Scientific reports, 12
\n \n \n \n\n \n
\n \n \nChristensen P. et al, (2022), Wellcome Open Research, 6, 39 - 39
\n \n \n \n\n \n
\n \n \nZhu L. et al, (2022), Communications Biology, 5
\n \n \n \n\n \n
\n \n \nDas S. et al, (2022), Malaria journal, 21
\n \n \n \n\n \n
\n \n \nKimingi HW. et al, (2022), Frontiers in immunology, 13
\n \n \n \n\n \n
\n \n \nSudsumrit S. et al, (2022), Frontiers in pharmacology, 13
\n \n \n \n\n \n
\n \n \nPakparnich P. et al, (2021), Scientific reports, 11
\n \n \n \n\n \n
\n \n \nSaito M. et al, (2021), BMC Medicine, 19
\n \n \n \n\n \n
\n \n \nMukaka M. et al, (2021), Malaria Journal, 20
\n \n \n \n\n \n
\n \n \nSugaram R. et al, (2021), Malaria journal, 20
\n \n \n \n\n \n
\n \n \nChi PC. et al, (2021), Trials, 22
\n \n \n \n\n \n
\n \n \nImwong M. et al, (2021), Antimicrobial Agents and Chemotherapy, 65
\n \n \n \n\n \n
\n \n \nMcLean ARD. et al, (2021), The Lancet Infectious Diseases, 21, 1579 - 1589
\n \n \n \n\n \n
\n \n \nChu CS. et al, (2021), Antimicrobial Agents and Chemotherapy, 65
\n \n \n \n\n \n
\n \n \nHamaluba M. et al, (2021), The Lancet Infectious Diseases, 21, 1395 - 1406
\n \n \n \n\n \n
\n \n \nPalasuwan D. et al, (2021), The Journal of infectious diseases
\n \n \n \n\n \n
\n \n \nChu CS. et al, (2021)
\n \n \n \n\n \n
\n \n \nMaude RJ. et al, (2021), BMJ Open, 11, e045900 - e045900
\n \n \n \n\n \n
\n \n \nChamchoy K. et al, (2021), Acta tropica, 217
\n \n \n \n\n \n
\n \n \n